From Our Partners
Friday, June 24, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

Anti-Bacterial Fabrics for Fight Against Superbugs

by Global Biodefense Staff
March 6, 2016
Prototype anti-super-bacterial masks

Prototype anti-super-bacterial masks. Credit: UNIST

An industry-academic collaborative group affiliated with Ulsan National Institute of Science and Technology (UNIST) has successfully engineered anti-bacterial fabrics that are effective against the super-bacterium, Staphylococcus aureus.

This anti-bacterial fabric was developed using a natural bacterial pigment called ‘Violacein’, which is violet pigment naturally made by bacteria found in nature, and is reported to have antibacterial, antiviral, antiprotozoal and anticancer effects.

See also: Superbugs and Superdrugs: An Interview with BARDA

The research team at UNIST, led by Prof. Robert J. Mitchell, extracted crude violacein using a self-developed production method and this was used to dye the cotton fabric. The team discovered that this fabric blocked the growth of MRSA and other multi-drug resistant S. aureus strains by 99.9%.

This widespread use of antibiotics has resulted in the ongoing and ever-increasing prevalence of antibiotic-resistant bacteria, with more than 0.7 million patients dying each year from these “superbugs”. Moreover, nosocomial infections, otherwise known as hospital-acquired infections, have become a growing problem worldwide and South Korea is no exception, scientists say.

See also: Antibiotic Resistant Bacteria Countermeasure Accelerator

“This is first case where an antibacterial fabric was produced using violacein. This fabric has the possibility to reduce the impact of super-bacterial infections,” said Prof. Mitchell. “We hope this donation will help public health.”

The work was supported by a grant from the Korea Institute for Advancement of Technology (KIAT) through the EUREKA program.

From Our Partners
Tags: AntimicrobialsAntiviralsASPRBARDAHHS

Related Posts

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America
Infectious Diseases

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America

June 10, 2022
Pathogens

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC